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Abstract: The pKa values of twelve β-hydroxy-β-arylalkanoic acids and ibupro-
fen were determined using a modified RP-HPLC method. The stationary phase 
was octadecyl modified (C-18) silica gel, and the mobile phases were mixtures 
of methanol and one of ten different buffers (60:40 volume ratio). The mean 
retention time of each compound was plotted against the pH of each of the ten 
used mobile phases. The inflection point of the obtained sigmoidal curve repre-
sents the sw apK  of a compound. Using sw apK in previously established equat-
ions for the specific methanol/buffer mixture, the ww apK values (in pure water) 
were calculated. The obtained ww apK values for the synthesized compounds 
were in a range from 3.40 to 3.74, and the ww apK for ibuprofen was 4.27. The 
Predicted pKa values for this type of compounds in the MarvinSketch 5.11.5. 
Program were in poor correlation with the experimental results, while in ACD/ 
/I-Labs pKa values were calculated as a wide range. 
Keywords: dissociation constant; anti-inflammatory compounds; ibuprofen; 
liquid chromatography; carboxylic acids. 
INTRODUCTION 
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used for decades 
to treat fever, pain and inflammation.1 The search for new NSAIDs is still a chal-
lenge because of non-selective gastric side effects2 and cardiovascular side 
effects of selective NSAIDs.3 The aqueous dissociation constant (Ka) is a phys-
icochemical parameter that has a great impact on the biopharmaceutical para-
meters of each drug candidate.4 The negative logarithm of the aqueous dissoci-
ation constant, pKa, affects the solubility, permeability through biological mem-
branes,5 receptor binding process of a compound6 and the choice of optimal con-
ditions in drug analysis.  
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Determination of pKa values at the early stage of screening of any newly 
synthesized, potentially biologically active compound is highly desirable. The 
prediction of pKa values using computational methods is very attractive but not 
always applicable. Two frequently used programs for estimating pKa values are 
MarvinSketch 5.11.57 and ACD/I-Labs.8 These programs have a fragment-based 
approach and they are inadequate if the fragments present in a studied molecule 
are absent from the database, and hence the estimated values can only be con-
sidered as approximate.  
Different approaches could be used for pKa determination, such as potentio-
metric titration,9 spectrophotometric titration,10,11 capillary electrophoresis,12,13 
reversed-phase chromatography14,15 and nuclear magnetic resonance.16,17 Rev-
ersed phase high performance liquid chromatography (RP-HPLC) methods are 
widespread and their advantages are that they are simple, only a small amount of 
compound is needed and the examined compounds need not to be of high purity. 
The latter is very convenient when the pKa for synthesized compounds should be 
determined.18 
Since NSAIDs are poorly soluble in water, the pKa values are often deter-
mined in mixtures of organic solvent (S, dimethyl sulfoxide, methanol, ethanol, 
propan-2-ol, acetone or tetrahydrofuran) and water. Methanol shows a solvation 
effect closest to that of water and it is often used as a solvent of choice for pKa 
determination.  
β-Hydroxy-β-arylalkanoic acids were previously synthesized and their anti- 
-inflammatory activity was evaluated.19–21 The general aim of the previous 
studies was to examine the impact of some structural modifications on selectivity 
towards COX-2 inhibition. The aim of this study was to determine pKa values of 
previously synthesized β-hydroxy-β-arylalkanoic acids. Considering that the syn-
thesized compounds are weak acids sparingly soluble in water and having the 
same phenylpropanoic moiety as ibuprofen, the modified chromatographic 
method reported by Oumada et al. was used.22  
EXPERIMENTAL 
The chemical structures of tested compounds, which were previously synthesized using 
modification of the Reformatsky reaction and fully characterized, are shown in Table I. 
Solvents. Methanol, HPLC grade (J. T. Baker, Deventer, Netherlands), orthophosphoric 
acid 85 %, (Merck, Darmstadt, Germany), acetic acid, glacial (Merck, Darmstadt, Germany), 
deionized water (TKA system for water purification, Niederelbert, Germany). 
Solid substances. Ibuprofen 99 % (Alfa Aesar, Karlsruhe, Germany), and potassium 
dihydrogen phosphate p.a., sodium acetate p.a., disodium phosphate p.a. and potassium bro-
mide p.a. (Merck, Darmstadt, Germany). 
Apparatus. The sw apK values of the used mobile phases were measured on a Radiometer 
model PHM 240 pH/ion-meter (Radiometer, Copenhagen, Denmark). The HPLC analyses 
were conducted on Agilent HPLC instrument, equipped with a binary pump, a 20-µL loop 
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valve and a DAD detector. The obtained results were processed with ChemStation software 
(Agilent Technologies, USA). 














                                                                                                               Ibuprofen 
Compound R1 R2 R3 R4 R5 
1A –H –H –CH3 –H –C6H5 
1C –CH3 –CH3 –CH3 –H –C6H5 
2A –CH3 –CH3 –C6H5 –H –H 
2B –H –H –C6H5 –H –H 
2C –H –CH3 –C6H5 –H –H 
2APN –CH3 –CH3 –C6H5 –H –NO2 
2APTF –H –H –C6H5 –H –CF3 
2APH –H –H –C6H5 –H –Cl 
2APM –H –H –C6H5 –H –CH3 
2AMTF –H –H –C6H5 –CF3 –H 
2AMH –H –H –C6H5 –Cl –H 
2AMM –H –H –C6H5 –CH3 –H 
Procedure. The potentiometric system was standardized with ordinary aqueous buffers, 
pH 1.679, 4.005, 7.006 and 9.18 (Radiometer Analytical, Villeurbanne Cedex, France). The 
ww apK  values of the aqueous buffers were measured, as well as the sw apK  values of the pre-
pared mobile phases. The compounds were dissolved in the mobile phase at a concentration of 
approximately 600 ppm. The HPLC analyses were performed on a Zorbax Eclipse XDB C18 
4.6 mm×150 mm, 3.5-µm column at a temperature of 25 °C at a flow rate of 1 mL min-1. 
Detection was realized at 254 nm. The mobile phase was a mixture of methanol and the 
appropriate buffer (60:40 volume ratio). The ten buffer solutions listed in Table II were pre-
pared so that the final strength was 0.01 mol m-3. The holdup time was determined with potas-
sium bromide. All measurements were performed in triplicate. 
TABLE II. Used buffers, their ww pH  values and the sw pH  values of the mobile phases 
Buffer ww pH  sw pH  
0.01 mol/L H3PO4 2.339 3.126 
0.007 mol L-1 CH3COOH + 0.003 mol L-1 CH3COONa 2.555 3.456 
0.005 mol L-1 H3PO4+ 0.005 mol L-1 KH2PO4 2.712 3.699 
0.001 mol L-1 H3PO4 + 0.009 mol L-1 KH2PO4 3.338 4.537 
0.01 mol L-1 CH3COOH 3.433 4.207 
0.009 mol L-1 CH3COOH + 0.001 mol L-1 CH3COONa 4.199 5.293 
0.005 mol L-1 CH3COOH + 0.005 mol L-1 CH3COONa 4.835 5.801 
0.001 mol L-1 CH3COOH + 0.009 mol L-1 CH3COONa 5.537 6.827 
0.007 mol L-1 KH2PO4 + 0.003 mol L-1 Na2HPO4 5.585 7.258 
0.005 mol L-1 KH2PO4 + 0.005 mol L-1 Na2HPO4 7.046 8.679 
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RESULTS AND DISCUSSION 
The mean of triplicate retention times was calculated for each compound and 
plotted against the pH value of each of the ten mobile phases (Figs. 1–4). 
According to the used method, the sw apK  values that represent the true thermo-
dynamic constant in a hydro-organic medium can be calculated from retention 
times of tested compounds in the chromatographic system (according to IUPAC 
nomenclature, the superscript “s” indicates organic solvent, while the subscript 
“w” indicates the solvent). The inflection point of the plotted sigmoidal curve 
represents the sw apK  value. The maximum and minimum retention times are 
given in Table III. The sw apK  and ss apK  values differ by a constant value δ, 
which depends solely on the hydro-organic solvent. The δ values for a number of 
water–methanol mixtures are well established.23  
Fig. 1. Variation of retention time of 
compounds 1A and 1C with the pH of the 
mobile phase. 
 
Fig. 2. Variation of retention time of 
compounds 2A, 2B and 2C with the pH of 
the mobile phase. 
The linear relationship between ss apK  and ww apK  was predicted by Izma-
ilov24,25 and Rived et al.:26 
 s ws a w ap pK bKa= +  (1) 
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The constants a and b depend on the composition of the methanol/water 
mixture, and their values can easily be calculated from the percentage methanol 
using already established equations. Their value for the used mixture of meth-
anol/buffer (60:40 volume ratio) is known.27 
Fig. 3. Variation of retention time of 
compounds 2APN, 2APTF, 2APH, 
2APM, 2AMTF, 2AMH and 2AMM 
with the pH of the mobile phase. 
Fig. 4. Variation of retention time of ibuprofen 
with the pH of the mobile phase. 
The mentioned method could be used under specific terms: a methanol/ 
/buffer mixture for which constants a and b are known must be used and the 
tested compounds must be from the same family (in the present case, aromatic 
carboxylic acids). 
The ss apK  and ww apK  values were calculated using Eqs. (2) and (3): 






=  (3) 
where δ = 0.1756 (value taken from the literature for 60 vol. % of methanol); 
a = 1.364; b = 0.18.22 
The slope a in Eq. (3) depends only on the specific solvation term deter-
mined by the solvent and family of the compounds studied.27 Chantooni and 
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Kolthoff28 showed that the slope value measures the resolution of acid strength 
of the family of the compounds in the solvent s in reference to water. This 
approach has been well established for the pKa values of families of compounds 
in different solvents in reference to pKa values in water.26,29–31 It was shown that 
more precise pKa values for diclofenac, flurbiprofen, naproxen, ibuprofen, 
butibufen and fenbufen are obtained using a and b constants for non-ortho-
substituted aromatic carboxylic acids.22 Due to certain structural similarity 
between ibuprofen and the tested β-hydroxy-β-arylalkanoic acids, the same 
values of a and b were used. 
Calculated results for synthesized compounds and for ibuprofen are given in 
Table III. 
TABLE III. Experimental and predicted ww apK  values for the tested compounds 
Compound tR(HA) min 
tR(A) 
min 
sw apK  ss apK  ww apK  
ww apK  
MarvinSketch
ww apK  
ACD/I-Labs 
1A 12.17 3.18 4.90 4.73 3.60 4.53 4.40±0.40 
1C 11.17 3.15 5.10 4.93 3.74 4.54 4.40±0.40 
2A 22.44 3.33 5.04 4.87 3.70 4.73 4.10±0.40 
2B 18.62 2.53 4.96 4.79 3.64 4.73 4.10±0.40 
2C 24.01 3.79 5.00 4.83 3.67 4.72 4.10±0.40 
2APN 22.02 8.12 4.80 4.63 3.52 3.53 3.90 
2APTF 29.01 10.37 4.75 4.58 3.49 4.17 4.00±0.50 
2APH 21.76 7.40 4.72 4.54 3.46 4.08 3.90±0.50 
2APM 17.28 5.64 4.74 4.56 3.48 4.52 4.10±0.50 
2AMTF 23.06 8.20 4.73 4.55 3.47 4.17 4.00±0.50 
2AMH 21.60 8.26 4.72 4.54 3.46 4.08 3.90±0.50 
2AMM 13.15 3.69 4.64 4.46 3.40 4.52 4.10±0.50 
Ibuprofen 42.06 7.02 5.82 5.65 4.27 4.85 4.41±0.10 
The original procedure was modified in that four of the original mobile 
phases were replaced with three new ones (0.005 mol L–1 H3PO4 + 0.005 mol L–1 
KH2PO4, 0.007 mol L–1 CH3COOH + 0.003 mol L–1 CH3COONa, 0.007 mol L–1 
KH2PO4 + 0.003 mol L–1 Na2HPO4). The four replaced mobile phases in the 
original method consisted of citric acid, potassium dihydrogen citrate, potassium 
sodium hydrogen citrate and sodium citrate. Instead of them, amounts of phos-
phate and acetic buffers (which were also used in the original method) were 
adjusted to ensure they had the same pH values as the replaced ones. The mobile 
phase preparation was simplified by using fewer substances in the buffers while 
appropriate pH range was achieved (3.126 to 8.679, Table II). It was taken into 
account that these pH values were compatible with the used column. The ionic 
strength of used mobile phases was low (10 mol m–3) and had negligible effect 
on pKa values. 
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Methanol content in the mobile phase was high in order to obtain reasonable 
retention times. From the solubility aspect, the use of methanol is desirable, 
because it increases the solubility of most organic compounds. In addition, its 
relatively high dielectric constant allows the solvation of ionic solutes and the 
prevention of ion-pair formation, at least at not very high solute concentrations.  
The obtained pKa value for ibuprofen (4.27) was well reproduced concerning 
the value already reported (4.30). All the tested compounds, including ibuprofen, 
have an acidic carboxylic group in their structure. All the synthesized compounds 
could be considered as derivatives of hydroxypropionic acid, which explains the 
lower pKa values in comparison to that of ibuprofen, a derivative of propionic acid. 
All the compounds have similar pKa values in range from 3.40 to 3.74. Com-
paring the pairs of positional isomers: 2APTF and 2AMTF, 2APH and 2AMH, 
and 2APM and 2AMM, it could be concluded that the position of the substituent 
(meta or para) had no significant impact on dissociation constants, which was 
expected. The type of substituent (nitro, trifluoromethyl, chloro or methyl) also 
had no impact on protonation because the carboxylic group is not directly 
attached to the benzene ring. The influence of substitution of side branch with 
methyl groups had negligible effect on dissociation constant, and hence, there 
was no significant difference in pKa values between compounds 1A and 1C, 
which are derivatives of β-hydroxy-β-biphenylylbutanoic acid, nor among 2A, 
2B and 2C, which are derivatives of β-hydroxy-β,β-diphenylpropanoic acid. 
Compound 2A has the highest pKa value. 
The pKa values of the tested compounds and ibuprofen were predicted using 
standard software MarvinSketch and ACD/I-Labs program and the results are 
presented in Table III. It could be seen that there is poor correlation between the 
pKa values predicted by the MarvinSketch program both for the synthesized com-
pounds and ibuprofen (R2 = 0.3126). The experimental results fall into the range 
predicted by the ACD/I-Labs program, but the range is very wide and hence, 
neither of these programs is suitable for pKa prediction for these compounds.  
On the molecular level, acidic compounds with carboxylic groups inhibit 
both COX-1 and COX-2 by maintaining one of the most important interactions – 
salt bridges with Arg120. It is desirable for these compounds to have low pKa 
values, which ensure their existence in the ionized form at the physiological pH 
(7.4). In inflamed tissue, the pH level is decreased compared to the physiological 
value32 and thus, it could be concluded that it is ensured that the examined 
β-hydroxy-β-arylalkanoic acids will be almost completely ionized at lower pH 
values compared to ibuprofen, which will promote salt bridge formation.  
CONCLUSIONS 
The pKa values of β-hydroxy-β-arylalkanoic acids, which exhibit anti-inf-
lammatory activity, and ibuprofen were determined using the RP-HPLC method 
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by Oumada et al. It is shown that this method could be used in pKa determination 
of compounds that are derivatives of hydroxypropionic acids. The pKa values of 
all the synthesized compounds were lower than the pKa of ibuprofen, which is a 
derivative of propionic acid. Correlation between the results calculated using the 
MarvinSketch program and the experimental results is very poor and this prog-
ram cannot be used for the prediction of the pKa values of this type of compound. 
The ACD/I-Lab program is also inadequate because it gives only a wide range of 
pKa values. The lower pH values of the synthesized compounds would promote 
inhibition of COX because of the formation of salt bridges between Arg120 with 
the ionized form of the compound in comparison to ibuprofen.  
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И З В О Д  
ОДРЕЂИВАЊЕ pKa ВРЕДНОСТИ СИНТЕТИСАНИХ β-ХИДРОКСИ-β-АРИЛАЛКАНСКИХ 
КИСЕЛИНА МОДИФИКОВАНОМ RP-HPLC МЕТОДОМ 
ЈЕЛЕНА С. САВИЋ, САНДА П. ДИЛБЕР, ЗОРИЦА Б. ВУЈИЋ, СОТЕ М. ВЛАДИМИРОВ и ЈАСМИНА С. БРБОРИЋ  
Универзитет у Београду, Фармацеутски факултет, Војводе Степе 450, 11221 Београд 
pKa вредности су одређене за дванаест β-хидрокси-β-арилалканских киселина и 
ибупрофен применом модификоване RP-HPLC методе. Стационарна фаза је била окта-
децил-модификовани (C-18) силикагел, а мобилне фазе су се састојале од смеше мета-
нола и једног од десет пуфера (запремински однос 60:40). За свако једињење је изра-
чуната средња вредност ретенционих времена и конструисан је график зависности доби-
јене вредности од pH вредности мобилне фазе. Превојна тачка на сигмоидалној кривој 
представља sw apK  за свако тестирано једињење. Кад се вредност sw apK  за свако тести-
рано једињење уврсти у претходно утврђене једначине за специфичну смешу метанола и 
воде израчунава се вредност ww apK  (у чистој води). Добијене вредности су у опсегу од 
3,40 до 3,74, а за ибупрофен је добијена вредност 4,27. Корелација између експери-
ментално одређених pKa вредности и вредности предвиђених помоћу програма Marvin-
Sketch 5.11.5. је незадовољавајућа, док су у програму ACD/I-Labs pKa вредности израчу-
нате као веома широк опсег. 
(Примљено 4. августа 2017, ревидирано 9. марта, прихваћено 13. априла 2018) 
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